Hepatitis C is a viral infection that primarily affects the liver and can cause both acute and chronic disease.

Anyone at risk of hepatitis C exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through unsafe injection practices, blood transfusions before 1992, and other high-risk behaviors.

Yes, the HCV Spot Test is highly accurate in detecting antibodies against hepatitis C virus. However, a positive result requires confirmation through additional tests.

No, additional tests are needed to differentiate between acute and chronic hepatitis C infection.

A positive result indicates possible hepatitis C infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.

The duration varies but generally lasts between 1 to 4 hours, depending on the complexity and extent of the surgery.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.